<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-15289</title>
	</head>
	<body>
		<main>
			<p>940709 FT  09 JUL 94 / International Company News: US drug group sale American Cyanamid, the US pharmaceuticals company, has agreed in principle to sell its Davis &amp; Geck wound management business to its European joint venture partner, B. Braun Melsungen of Germany, Reuter reports. Terms were not disclosed. Cyanamid said it would maintain its manufacturing operations in Puerto Rico. The sale is subject to reaching definitive agreements and gaining government approvals. The two companies are partners in joint venture wound management companies in Germany, Portugal and Spain. Under this agreement, B. Braun will acquire Cyanamid's worldwide business, including surgical sutures and endoscopic products. Cyanamid said Davis &amp; Geck had 1993 sales of Dollars 300m.</p>
		</main>
</body></html>
            